Recombinant Human ODC1 Protein ，His & SUMO

ODC1, or Ornithine Decarboxylase 1, is a key enzyme in the polyamine biosynthesis pathway, catalyzing the conversion of ornithine to putrescine, a crucial precursor for various polyamines like spermidine and spermine. The significance of ODC1 extends beyond basic cellular metabolism, as polyamines are implicated in a variety of physiological processes, including cell growth, differentiation, and apoptosis. Aberrant regulation or overexpression of ODC1 has been linked to several pathological conditions, particularly cancer, where enhanced polyamine synthesis can promote tumorigenesis and cell proliferation. Consequently, ODC1 has garnered attention as a potential therapeutic target in cancer treatment, leading to the development of ODC inhibitors. Over the years, researchers have made significant strides in understanding the structure, function, and regulation of ODC1, utilizing recombinant protein techniques to produce ODC1 for in-depth biochemical studies. This recombinant ODC1 protein not only facilitates the exploration of its enzymatic properties but also aids in investigating the impacts of various inhibitors, thus providing insights into its role in disease mechanisms. Additionally, elucidating the regulatory networks involving ODC1 can open avenues for novel therapeutic strategies aimed at modulating polyamine levels in pathological states. This accumulating body of knowledge underscores the importance of ODC1 in both fundamental biology and clinical applications, paving the way for innovative approaches in combating diseases influenced by polyamine dysregulation.